Back to Article List

Four human-identical milk oligosaccharides authorized to be used in infant formula


Sep 27, 2023

Food Standards Australia New Zealand (FSANZ) has published Notice 263-23, which approved application A1265 to allow the voluntary use of four human milk oligosaccharide components as nutrients in infant formula, either alone or in combination.

The following four human-identical milk oligosaccharide (HiMO) ingredients produced by microbial fermentation are now authorized to be used, alone or in combinations, as nutritive substances in infant formula products (IFP):

  • Mixture of 2'-fucosyllactose (2'-FL) and difucosyllactose (DFL) (“2' FL/DFL");
  • Lacto-N-tetraose (LNT);
  • 6'-Sialyllactose (6'-SL) sodium salt; and
  • 3'-Sialyllactose (3'-SL) sodium salt.

The four HiMO ingredients are produced from the same genetically engineered Escherichia coli (E. coli) K-12-derived platform strain as Glycom's 2'-FL and LNnT which is already authorised for use in Australia and New Zealand.​

For further information (in English), click on the Link

Related Articles
See All News
Subscribe to our newsletter

The best industry insight in your mailbox